and that has included semaglutide and tirzepatide, the main ingredients in two different FDA-approved diabetes and weight loss drugs. “I did my research, and found what I believed to be a reputable ...

Pharmacies that make customized medications are asking the federal Food and Drug Administration to protect their right to ...

Novo said in a statement it wanted to ensure patients only received FDA-approved, safe, and effective semaglutide products.

Compounded semaglutide: Medication produced by compounded pharmacies ... A telehealth provider that can prescribe GLP-1 ...

With brand-name GLP-1s for obesity treatment on and off the shortage list, prescribing can get complicated. Five providers ...

Amid a decade-high surge in drug shortages, the American Medical Association has adopted new policy measures aimed at addressing the crisis.

The makers of Ozempic and Zepbound are fighting to stop compounded copies of their drugs. But it’s unclear whether they can ...

Hims & Hers is launching a tracker of GLP-1 shortages to push back against the FDA's recent moves to end compounding copycats ...

Understanding the right dose of Ozempic for you can feel a bit confusing, especially if you’re just getting started. While ...

Novo Nordisk and Eli Lilly are facing scores of personal injury claims for allegedly failing to warn patients about side ...